Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title:Meet Our Editorial Board Member
Volume: 10 Issue: 2
Author(s): Alexander K. C. Leung*
Affiliation:
- Department of Pediatrics, The University of Calgary and Alberta Children's Hospital, Calgary, Alberta,Canada
Export Options
About this article
Cite this article as:
Leung K. C. Alexander*, Meet Our Editorial Board Member, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2016; 10 (2) . https://dx.doi.org/10.2174/187221481002170518175126
DOI https://dx.doi.org/10.2174/187221481002170518175126 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
13
Related Articles
-
Factors which Influence the Levels of ST-2, Galectin-3 and MMP-9 in Acute Coronary Syndrome
Cardiovascular & Hematological Disorders-Drug Targets An Overview on Natural Polysaccharides with Antioxidant Properties
Current Medicinal Chemistry Early Life and Oxidative Stress in Psychiatric Disorders: What Can we Learn From Animal Models?
Current Pharmaceutical Design The Effects of Obesity-Related Peptides on the Vasculature
Current Vascular Pharmacology GLP-1 Agonists Exenatide and Liraglutide: A Review About Their Safety and Efficacy
Current Clinical Pharmacology Stem Cell Pharmacogenomics
Current Topics in Medicinal Chemistry Dietary Small Molecules and Large-Scale Gene Expression Studies: An Experimental Approach for Understanding their Beneficial Effects on the Development of Malignant and Non-Malignant Proliferative Diseases
Current Medicinal Chemistry Targeting Redox Signaling in the Vascular Wall: From Basic Science to Clinical Practice
Current Pharmaceutical Design An Update on the Roles of the Complement System in Autoimmune Diseases and the Therapeutic Possibilities of Anti-Complement Agents
Current Drug Therapy Disturbed Homeostasis in Patients with Acute Psychosis
Current Psychiatry Reviews Potential Therapeutic Properties of Natural Products Through the Expression of Heme Oxygenase-1
Mini-Reviews in Organic Chemistry Dissecting Insulin Signaling Pathways: Individualised Therapeutic Targets for Diagnosis and Treatment of Insulin Resistant States
Endocrine, Metabolic & Immune Disorders - Drug Targets Role of the Decreased Nitric Oxide Bioavailability in the Vascular Complications of Diabetes Mellitus
Current Pharmaceutical Biotechnology Phycobilins and Phycobiliproteins Used in Food Industry and Medicine
Mini-Reviews in Medicinal Chemistry Current Trends in Enzyme Inhibition and Docking Analysis in Drug Design-Part -II
Current Topics in Medicinal Chemistry GATA-3 as a Potential Therapeutic Target for Insulin Resistance and Type 2 Diabetes Mellitus
Current Diabetes Reviews Polyphenols and Stem Cells for Neuroregeneration in Parkinson’s Disease and Amyotrophic Lateral Sclerosis
Current Pharmaceutical Design Psoriasis and Atherosclerosis: Is There a Need For Novel Biomarkers Assessing Cardiovascular Risk?
Current Pharmaceutical Design Antihypertensive Treatment with Beta-Blockers in the Metabolic Syndrome: A Review
Current Diabetes Reviews Mango Polyphenols and Its Protective Effects on Diseases Associated to Oxidative Stress
Current Pharmaceutical Biotechnology